10.6084/m9.figshare.7514246.v1
Jane Mary de Medeiros Guimarães
Jane Mary de Medeiros
Guimarães
Erika Santos Aragão
Erika Santos
Aragão
Fábio Sanches dos Santos Galdino
Fábio Sanches dos Santos
Galdino
Bethania de Araújo Almeida
Bethania de Araújo
Almeida
Sebastião Antonio Loureiro de Souza Silva
Sebastião Antonio Loureiro de Souza
Silva
Technological paradigms and trajectories in health: challenges of innovation in the care of diabetes
SciELO journals
2018
Innovation
Diffusion of innovation
Diabetes Mellitus
Hypoglycemic Agents
2018-12-26 04:55:01
Dataset
https://scielo.figshare.com/articles/dataset/Technological_paradigms_and_trajectories_in_health_challenges_of_innovation_in_the_care_of_diabetes/7514246
<p></p><p>ABSTRACT In the health sector, the incorporation of innovations has contributed to an increased demand for public services, as well as technologies and the supplies used in the provision of health services. One of the health sectors which causes most pressures on services in terms of the incorporation of its products is the pharmaceutical industry. This study aims to describe the technological trajectories in the segment of anti-diabetic medication launched in Brazil between 1998 and 2012. These drugs represent a significant proportion of spending on medicine in the Country. By using a qualitative, descriptive and exploratory methodology, the present study endeavored to answer the following questions: have changes taken place in the technological trajectories over the time period considered herein? Have the innovations incorporated in the Country been of an incremental or radical nature? What are the evidences that support these changes in direction? In light of the data collected from a variety of databases, it was possible to verify that the anti-diabetic medications introduced during this period represented incremental innovations with respect to the technological trajectories considered herein.</p><p></p>